• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支气管扩张症恶化中的综合微生物组学

Integrative microbiomics in bronchiectasis exacerbations.

机构信息

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.

Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore.

出版信息

Nat Med. 2021 Apr;27(4):688-699. doi: 10.1038/s41591-021-01289-7. Epub 2021 Apr 5.

DOI:10.1038/s41591-021-01289-7
PMID:33820995
Abstract

Bronchiectasis, a progressive chronic airway disease, is characterized by microbial colonization and infection. We present an approach to the multi-biome that integrates bacterial, viral and fungal communities in bronchiectasis through weighted similarity network fusion ( https://integrative-microbiomics.ntu.edu.sg ). Patients at greatest risk of exacerbation have less complex microbial co-occurrence networks, reduced diversity and a higher degree of antagonistic interactions in their airway microbiome. Furthermore, longitudinal interactome dynamics reveals microbial antagonism during exacerbation, which resolves following treatment in an otherwise stable multi-biome. Assessment of the Pseudomonas interactome shows that interaction networks, rather than abundance alone, are associated with exacerbation risk, and that incorporation of microbial interaction data improves clinical prediction models. Shotgun metagenomic sequencing of an independent cohort validated the multi-biome interactions detected in targeted analysis and confirmed the association with exacerbation. Integrative microbiomics captures microbial interactions to determine exacerbation risk, which cannot be appreciated by the study of a single microbial group. Antibiotic strategies probably target the interaction networks rather than individual microbes, providing a fresh approach to the understanding of respiratory infection.

摘要

支气管扩张症是一种渐进性的慢性气道疾病,其特征是微生物定植和感染。我们提出了一种多组学方法,通过加权相似网络融合(https://integrative-microbiomics.ntu.edu.sg)整合支气管扩张症中的细菌、病毒和真菌群落。处于加重风险最高的患者的微生物共现网络的复杂性较低,气道微生物组的多样性降低,拮抗相互作用的程度更高。此外,纵向相互作用组动力学揭示了加重期间的微生物拮抗作用,在多组学稳定的情况下,这种拮抗作用在治疗后得到解决。假单胞菌相互作用组的评估表明,相互作用网络而不仅仅是丰度与加重风险相关,并且纳入微生物相互作用数据可以改善临床预测模型。独立队列的鸟枪法宏基因组测序验证了靶向分析中检测到的多组学相互作用,并证实了与加重的关联。综合微生物组学可以捕捉微生物相互作用来确定加重风险,而这是单个微生物组研究无法理解的。抗生素策略可能针对相互作用网络而不是单个微生物,为理解呼吸道感染提供了一种新方法。

相似文献

1
Integrative microbiomics in bronchiectasis exacerbations.支气管扩张症恶化中的综合微生物组学
Nat Med. 2021 Apr;27(4):688-699. doi: 10.1038/s41591-021-01289-7. Epub 2021 Apr 5.
2
Airway "Resistotypes" and Clinical Outcomes in Bronchiectasis.气道“抵抗型”与支气管扩张症的临床结局
Am J Respir Crit Care Med. 2024 Jul 1;210(1):47-62. doi: 10.1164/rccm.202306-1059OC.
3
Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease.宏基因组学揭示了与慢性呼吸道疾病相关的微生物群核心大环内酯类耐药组。
Am J Respir Crit Care Med. 2020 Aug 1;202(3):433-447. doi: 10.1164/rccm.201911-2202OC.
4
Bacterial interactome disturbance in chronic obstructive pulmonary disease clinical stability and exacerbations.慢性阻塞性肺疾病临床稳定期和加重期细菌相互作用组紊乱。
Respir Res. 2024 Apr 20;25(1):173. doi: 10.1186/s12931-024-02802-5.
5
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.支气管扩张症患者的痰微生物组与临床结局:一项前瞻性观察研究。
Lancet Respir Med. 2021 Aug;9(8):885-896. doi: 10.1016/S2213-2600(20)30557-9. Epub 2021 May 4.
6
Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis.支气管扩张症中肠道-肺部轴的微生物失调。
Am J Respir Crit Care Med. 2023 Apr 1;207(7):908-920. doi: 10.1164/rccm.202205-0893OC.
7
Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study.支气管扩张症加重的表型:一项观察性队列研究。
Am J Respir Crit Care Med. 2024 Jul 1;210(1):77-86. doi: 10.1164/rccm.202310-1729OC.
8
genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasis.基因型影响非 CF 支气管扩张症的肺功能、加重频率和气道微生物群。
Thorax. 2017 Apr;72(4):304-310. doi: 10.1136/thoraxjnl-2016-208775. Epub 2016 Aug 8.
9
Differential airway resistome and its correlations with clinical characteristics in Haemophilus- or Pseudomonas-predominant microbial subtypes of bronchiectasis.支气管扩张症中以流感嗜血杆菌或铜绿假单胞菌为主的微生物亚型的气道差异抗性组及其与临床特征的相关性。
Respir Res. 2023 Nov 2;24(1):264. doi: 10.1186/s12931-023-02562-8.
10
Microbiological characteristics of the lower airway in adults with bronchiectasis: a prospective cohort study.成人支气管扩张症下呼吸道的微生物学特征:一项前瞻性队列研究。
Respir Res. 2024 Jul 17;25(1):283. doi: 10.1186/s12931-024-02903-1.

引用本文的文献

1
Pseudomonas aeruginosa-driven airway dysbiosis and machine learning prediction of acute exacerbations in non-cystic fibrosis bronchiectasis: a microbial-inflammatory signature approach.铜绿假单胞菌驱动的气道生态失调与非囊性纤维化支气管扩张症急性加重的机器学习预测:一种微生物-炎症特征方法
BMC Pulm Med. 2025 Sep 1;25(1):419. doi: 10.1186/s12890-025-03892-7.
2
Sputum Microbiota Compositions Correlate With Metabolome and Clinical Outcomes of COPD-Bronchiectasis Association: A Prospective Cohort Study.痰液微生物群组成与慢性阻塞性肺疾病-支气管扩张症关联的代谢组及临床结局相关:一项前瞻性队列研究。
Exploration (Beijing). 2025 May 4;5(4):e20240149. doi: 10.1002/EXP.20240149. eCollection 2025 Aug.
3

本文引用的文献

1
Environmental fungal sensitisation associates with poorer clinical outcomes in COPD.环境真菌致敏与 COPD 的临床结局较差相关。
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.00418-2020. Print 2020 Aug.
2
Microbiome Multi-Omics Network Analysis: Statistical Considerations, Limitations, and Opportunities.微生物组多组学网络分析:统计考量、局限性与机遇
Front Genet. 2019 Nov 8;10:995. doi: 10.3389/fgene.2019.00995. eCollection 2019.
3
The microbiome of the upper respiratory tract in health and disease.上呼吸道微生物组与健康和疾病。
Beyond ORBIT: Mapping the Constellation of Pseudomonas Endotypes in Bronchiectasis Clinical Trials.
超越轨道:绘制支气管扩张症临床试验中假单胞菌内型图谱
Am J Respir Crit Care Med. 2025 Aug;211(8):1321-1323. doi: 10.1164/rccm.202506-1388ED.
4
Endotypes of Infection in Bronchiectasis Are Associated with Inhaled Antibiotic Response: Results from Two Randomized, Double-Blind, Placebo-controlled Phase III Trials (ORBIT 3 and ORBIT 4).支气管扩张症感染的内型与吸入性抗生素反应相关:两项随机、双盲、安慰剂对照的III期试验(ORBIT 3和ORBIT 4)的结果
Am J Respir Crit Care Med. 2025 Aug;211(8):1397-1408. doi: 10.1164/rccm.202501-0159OC.
5
Multi-kingdom microbiota analysis reveals bacteria-viral interplay in IBS with depression and anxiety.多菌群分析揭示了伴有抑郁和焦虑的肠易激综合征中细菌与病毒的相互作用。
NPJ Biofilms Microbiomes. 2025 Jul 5;11(1):129. doi: 10.1038/s41522-025-00760-4.
6
The role of T-helper and T regulatory cells in driving neutrophilic and eosinophilic inflammation in bronchiectasis.辅助性T细胞和调节性T细胞在支气管扩张症中引发嗜中性粒细胞性和嗜酸性粒细胞性炎症方面的作用。
Front Immunol. 2025 Jun 16;16:1598257. doi: 10.3389/fimmu.2025.1598257. eCollection 2025.
7
Integrative study of pulmonary microbiome and clinical diagnosis in pulmonary tuberculosis patients.肺结核患者肺部微生物群与临床诊断的综合研究。
Microbiol Spectr. 2025 Jun 20:e0156324. doi: 10.1128/spectrum.01563-24.
8
Short-term stability of the sputum microbiota in bronchiectasis and cystic fibrosis.支气管扩张症和囊性纤维化患者痰液微生物群的短期稳定性
ERJ Open Res. 2025 Jun 16;11(3). doi: 10.1183/23120541.00247-2024. eCollection 2025 May.
9
Sputum metagenomics in bronchiectasis reveals pan-European variation: an EMBARC-BRIDGE study.支气管扩张症痰液宏基因组学揭示泛欧洲差异:一项EMBARC - BRIDGE研究
Eur Respir J. 2025 Aug 22;66(2). doi: 10.1183/13993003.00054-2025. Print 2025 Aug.
10
The Respiratory Tract Microbiome and Human Health.呼吸道微生物群与人类健康
Microb Biotechnol. 2025 May;18(5):e70147. doi: 10.1111/1751-7915.70147.
BMC Biol. 2019 Nov 7;17(1):87. doi: 10.1186/s12915-019-0703-z.
4
Microbial communities in the tropical air ecosystem follow a precise diel cycle.热带空气生态系统中的微生物群落遵循精确的昼夜周期。
Proc Natl Acad Sci U S A. 2019 Nov 12;116(46):23299-23308. doi: 10.1073/pnas.1908493116. Epub 2019 Oct 28.
5
lionessR: single sample network inference in R.lionessR:R 中的单样本网络推断。
BMC Cancer. 2019 Oct 25;19(1):1003. doi: 10.1186/s12885-019-6235-7.
6
Fungal-bacterial diversity and microbiome complexity predict ecosystem functioning.真菌-细菌多样性和微生物组复杂性预测生态系统功能。
Nat Commun. 2019 Oct 24;10(1):4841. doi: 10.1038/s41467-019-12798-y.
7
The Human Gut Virome Is Highly Diverse, Stable, and Individual Specific.人类肠道病毒组高度多样化、稳定且具有个体特异性。
Cell Host Microbe. 2019 Oct 9;26(4):527-541.e5. doi: 10.1016/j.chom.2019.09.009.
8
Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.大环内酯类抗生素长期治疗成人支气管扩张症:一项个体参与者数据荟萃分析。
Lancet Respir Med. 2019 Oct;7(10):845-854. doi: 10.1016/S2213-2600(19)30191-2. Epub 2019 Aug 9.
9
The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis.吸入抗生素治疗成人支气管扩张症的疗效和安全性:系统评价和荟萃分析。
Lancet Respir Med. 2019 Oct;7(10):855-869. doi: 10.1016/S2213-2600(19)30185-7. Epub 2019 Aug 9.
10
Time to acknowledge, address, and take action against bronchiectasis.是时候认识、应对支气管扩张症并采取行动了。
Lancet Glob Health. 2019 Sep;7(9):e1162-e1163. doi: 10.1016/S2214-109X(19)30311-0.